Trial intelligence / Profile preview

Mobilization of Autologous Stem Cells for Transplantation in Plasma Cell Myeloma

NCT01547806Phase 2Completed

Sponsor
National Cancer Institute
Start
Feb 2012
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of plerixafor in multiple myeloma (MM), sponsored by National Cancer Institute. Started Feb 2012; status: completed.

02

Drugs

plerixafor
03

Conditions

multiple myeloma (MM)

Beyond the preview

Go deeper on NCT01547806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01547806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call